M. Kevin Slawin

Chief Strategy Officer at Arbor Rapha Capital Bioholdings Corp. I (ARCK), 2021-11-10
Director at Bellicum Pharmaceuticals Inc (BLCM), 2017-06-15

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
BLCM	$12.54	30,000	$376,215.00	294,982	2017-02-07	Filing
BLCM	$15.45	30,000	$463,539.00	324,982	2016-12-15	Filing
BLCM	$20.11	11,958	$240,530.39	354,982	2016-09-23	Filing
BLCM	$20.12	11,258	$226,549.24	84,206	2016-09-23	Filing
BLCM	$20.04	100	$2,004.00	366,940	2016-09-21	Filing